Use of magnolia figo extract in the manufacture of compound for reducing epidermal desquamation and promoting wound healing

#The present invention relates to a use of Magnolia figo extract, and particularly relates to a use of Magnolia figo extract in the manufacture of a compound for reducing epidermal desquamation and promoting wound healing.

#Human skin fibroblast and blood vessels around it become losing flexibility due to many factors such as aging, environment, food or sleep. At the same time, the collagen, which is originally rich in the skin, also gradually be lost, which cause poor skin condition. Therefore many biomedical materials and skin medical related products have been developing to relieve and improve skin conditions.

#Most known biomedical materials and skin medical related products contain animal-derived ingredients. The animal-derived ingredients usually have larger molecular weight and belong to macromolecular, causing problems of barely absorbed by skin or only absorbed by skin surface but unable to reach the deep layer of the skin. Thus, it is difficult to fundamentally improve or solve the skin problem. Furthermore, biomedical materials and skin medical related products made by animal-derived ingredients exist potentially controversy on moral level.

#FIG. 1A is a drawing illustrating the skin repair effect of a use of Magnolia figo extract in the manufacture of a compound for reducing epidermal desquamation and promoting wound healing according to an embodiment of the present invention;

#FIG. 1B is a drawing illustrating the skin repair effect of the use of Magnolia figo extract in the manufacture of the compound for reducing epidermal desquamation and promoting wound healing according to the embodiment of the present invention;

#FIG. 2A is a drawing illustrating the skin repair effect of a use of Magnolia figo extract in the manufacture of a compound for reducing epidermal desquamation and promoting wound healing according to another embodiment of the present invention;

#The preferred embodiments of the present invention are described in detail below with reference to FIG. 1 to FIG. 9. The description is used for explaining the embodiments of the present invention only, but not for limiting the scope of the claims.

#As shown in FIGS. 1A to 1B, in an embodiment of the present invention, a use of Magnolia figo extract in the manufacture of a compound for reducing epidermal desquamation and promoting wound healing is provided, wherein the Magnolia figo extract is Magnolia figo essential oil extract of 0.01 to 0.15 wt %; the compound includes a compound carrier, the compound carrier is a gel; and the compound is applied to skin surface.

#As shown in FIGS. 1A to 1B, the compound containing the Magnolia figo essential oil extract of 0.1 wt % and the gel is applied to desquamated skin surface, and the skin desquamation improvement effect of the compound in skin repair is observed according to the changes in the skin surface image. This experiment and other related experiments use the active skin surface analysis system (Visioscan® VC 98) to detect the condition of the skin surface and the results is presented with image and data, in which the image is intended to present skin structure and degree of dryness, the data of this experiment shows the percentage of the skin desquamation improvement effect, and the data of wound healing experiment shows the percentage of the wound healing improvement effect. FIG. 1A shows the skin condition of the subject's skin before the compound is applied, and it can be observed that the subject's skin shows obvious epidermal desquamation. FIG. 1B shows the skin condition after the compound is applied to the skin surface every day for 28 days, and it can be observed that the subject's epidermal desquamation has been significantly improved. The result of Visioscan® VC 98 shows that the subject's skin has a good skin desquamation improvement effect (for example: 81%).